4.3 Article

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders

期刊

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
卷 72, 期 12, 页码 1497-1505

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00228-016-2118-x

关键词

Confounding by indication; High-dimensional propensity scores; Unmeasured confounders; Omitted confounders

资金

  1. Canadian Network for Observational Drug Effect Studies (CNODES), a collaborating center of the Drug Safety and Effectiveness Network (DSEN) - Canadian Institutes of Health Research [DSE-111845]

向作者/读者索取更多资源

High-dimensional propensity scores (hdPS) can adjust for measured confounders, but it remains unclear how well it can adjust for unmeasured confounders. Our goal was to identify if the hdPS method could adjust for confounders which were hidden to the hdPS algorithm. The hdPS algorithm was used to estimate two hdPS; the first version (hdPS-1) was estimated using data provided by 6 data dimensions and the second version (hdPS-2) was estimated using data provided from only two of the 6 data dimensions. Two matched sub-cohorts were created by matching one patient initiated on a high-dose statin to one patient initiated on a low-dose statin based on either hdPS-1 (Matched hdPS Full Info Sub-Cohort) or hdPS-2 (Matched hdPS Hidden Info Sub-Cohort). Performances of both hdPS were compared by means of the absolute standardized differences (ASDD) regarding 18 characteristics (data on seven of the 18 characteristics were hidden to the hdPS algorithm when estimating the hdPS-2). Eight out of the 18 characteristics were shown to be unbalanced within the unmatched cohort. Matching on either hdPS achieved adequate balance (i.e., ASDD < 0.1) on all 18 characteristics. Our results indicate that the hdPS method was able to adjust for hidden confounders supporting the claim that the hdPS method can adjust for at least some unmeasured confounders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据